Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With Opioid Use Disorder Hospitalized With Serious Injection-related Infection
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to test a remotely delivered IOP program (SmartIOP) for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• English-speaking adults aged 18 and above
• Any DSM-5 substance use disorder
• Can identify at least 2 individuals who can act as points of contact following discharge from the hospital
Locations
United States
Massachusetts
Brigham and Women's Hospital
RECRUITING
Boston
Contact Information
Primary
Joji Suzuki, MD
jsuzuki2@bwh.harvard.edu
617-732-5752
Time Frame
Start Date: 2023-11-17
Estimated Completion Date: 2024-12
Participants
Target number of participants: 20
Treatments
Experimental: Treatment Group
The intervention to be developed and tested has two components: 1) the remotely delivered IOP (Smart IOP), and 2) a peer recovery coach to provide support and accountability to the participant.
Related Therapeutic Areas
Sponsors
Leads: Brigham and Women's Hospital
Collaborators: National Institute on Drug Abuse (NIDA), Mclean Hospital